Matinas BioPharma
MTNB
MTNB
50 hedge funds and large institutions have $12.6M invested in Matinas BioPharma in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$72.2K | |
| 2 | +$44.4K | |
| 3 | +$28.2K | |
| 4 |
Renaissance Technologies
New York
|
+$24K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.92K |
Top Sellers
| 1 | -$117K | |
| 2 | -$72K | |
| 3 | -$69.2K | |
| 4 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$65.2K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$47K |